Cranio : the journal of craniomandibular practice · 2025
JOSAQ: Development and Delphi-Vignette evaluation of a craniofacial-focused screening tool for obstructive sleep apnoea in oral and maxillofacial surgery.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jain Anuj
Аннотация
BACKGROUND: Undiagnosed obstructive sleep apnoea (OSA) presents risks in oral and maxillofacial surgery (OMFS), yet tools such as STOP-Bang often underperform in non-obese patients with craniofacial anomalies. This study aimed to develop and preliminarily assess the Jain's Obstructive Sleep Apnoea Questionnaire (JOSAQ), a craniofacial-focused screening tool tailored for OMFS practice.
METHODS: JOSAQ, a two-stage, 20-item instrument combining patient-reported symptoms and clinician-assessed craniofacial features, underwent Delphi consensus and vignette-based comparison with STOP-Bang. Fifteen experts participated in the Delphi process, and 20 clinicians rated 25 standardized clinical vignettes.
RESULTS: Content validity was high (S-CVI = 0.89). JOSAQ identified more high-risk cases than STOP-Bang (62% vs 44%, p < .01) with higher Inter-rater reliability (κ = 0.72 vs 0.64), and better clarity scores. Completion times were similar.
CONCLUSION: JOSAQ enhances screening sensitivity and inter-rater reliability without increasing assessment time, particulary benefiting non-obese patients with craniofacial anomalies. Multicentre validation against polysomnography is recommended.
METHODS: JOSAQ, a two-stage, 20-item instrument combining patient-reported symptoms and clinician-assessed craniofacial features, underwent Delphi consensus and vignette-based comparison with STOP-Bang. Fifteen experts participated in the Delphi process, and 20 clinicians rated 25 standardized clinical vignettes.
RESULTS: Content validity was high (S-CVI = 0.89). JOSAQ identified more high-risk cases than STOP-Bang (62% vs 44%, p < .01) with higher Inter-rater reliability (κ = 0.72 vs 0.64), and better clarity scores. Completion times were similar.
CONCLUSION: JOSAQ enhances screening sensitivity and inter-rater reliability without increasing assessment time, particulary benefiting non-obese patients with craniofacial anomalies. Multicentre validation against polysomnography is recommended.